To mark OSN’s 40th anniversary in publishing, we decided to take a look back at some of the major news and innovations in ophthalmology over the past 40 years with the following interactive timeline. This is a living timeline, so we welcome reader submissions of any events you think we should cover that are not listed here. Please send any suggestions to email@example.com.
Ocular Surgery News kicks off yearlong anniversary celebration
The team at Healio/Ocular Surgery News is delighted to announce our 40th year in publication and our 40th year of Richard L. Lindstrom, MD’s, collaboration on the editorial board.
Private equity ensures strong succession peace of mind for some practices
In the last 10 years, private equity has grown to become a larger part of ophthalmology.
Ocular Surgery News staff writer Michela Cimberle wins APEX Award for News writing
Ophthalmology groups urge reversal of Aetnas cataract surgery prior authorization policy
FDA approves Dextenza for treatment of ocular inflammation
FDA approves Tecnis Synergy Tecnis Synergy Toric II IOLs
Deep learning algorithms prediction of RNFL thickness gauges risk for glaucoma conversion
An OCT-trained deep learning algorithm’s predictions of retinal nerve fiber layer thicknesses from fundus photographs effectively predicted future development of visual field defects in eyes of glaucoma suspects.
Increasing myopia a growing public health concern
SLT as primary glaucoma treatment may offer reduced cost better efficacy than eye drops
Selective laser trabeculoplasty may be more effective and cheaper than eye drops when used as primary glaucoma management, Nathan Radcliffe, MD, said at the virtual OSN New York meeting.
Healio enhances user experience with reengineered website
Healio has launched a new, fully reengineered version of its website, delivering personalized news and education in an enhanced user experience to specialty health care professionals, the company announced.
Biodegradable Durysta approved to lower IOP
IOL technology enters new age
As bifocal IOLs become less popular in the United States and practically nonexistent overseas, trifocal and extended depth of focus lenses are becoming the go-to technology for refractive cataract surgery, with new lenses in development that will allow surgeons to improve on already impressive refractive target goals.
Light Adjustable Lens a disruptive technology in cataract surgery
Since its commercial rollout in July, the Light Adjustable Lens has been implanted in 18 sites across the country, offering surgeons simplified preoperative messaging and decision-making and delivering better vision for patients, according to a speaker.
FDA approves Alcon's AcrySof IQ PanOptix trifocal IOL
Bausch + Lomb launches Lotemax SM
FDA approves Rocklatan for open-angle glaucoma, ocular hypertension
Raindrop near vision inlay recalled
Mix-and-match approach expands uses for minimally invasive glaucoma surgery
Combining minimally invasive glaucoma surgery procedures is a feasible, versatile alternative for lowering IOP and minimizing the side effects of a surgical approach to glaucoma, according to one specialist.
Caffeine may be ally in preventing or retarding cataract
Despite Plaquenil dosing recommendations, retinal toxicity remains
The American Academy of Ophthalmology has published several dosing and screening recommendations for hydroxychloroquine to avoid potential retinal toxicity, yet some patients still experience permanent vision loss resulting from hydroxychloroquine retinopathy due to improper dosing of the drug and improper screening.
Surgeons hold strong opinions for and against FLACS vs. manual cataract surgery
Since its FDA approval in 2010, femtosecond laser-assisted cataract surgery has been an option for surgeons, a new method in their armamentarium along with the traditional manual phaco technique.
Bimatoprost sustained-release implant shows positive phase 3 data
Lindstrom is appointed president of the American Society of Cataract and Refractive Surgery
Study shows advantages of femtosecond laser-assisted cataract surgery
BELGRADE, Serbia — Femtosecond laser-assisted cataract surgery with the Femto LDV Z8 laser from Ziemer offers the advantages of repeatable and precise outcomes, best placement of the capsulotomy and optimized surgical planning with the patient in one position from the beginning to end of surgery, according to one speaker.
Opinions differ on private equity in ophthalmology
WAILEA, Hawaii — As part of a panel moderated by Candace S. Simerson, FASOA, COE, CMPE, Richard L. Lindstrom, MD, and Kevin Corcoran, COE, CPC, CPMA, FNAO, presented evidence as to whether private equity is a proper fit for ophthalmology.
The dos and don'ts of DMEK
Surgeons share helpful tips for making the transition to Descemet's membrane endothelial keratoplasty.
FDA approves Aerie's Rhopressa for glaucoma
FDA gives nod to Bausch + Lomb’s once-daily glaucoma drops
Consider patient perception of pain when planning cataract procedures
Cataract surgery is thought to be painless for most patients, but for the few who report discomfort during surgery, ophthalmologists can take precautions to limit pain.
Should I choose distance vision in both eyes, monovision, EDOFs or multifocals?
Jack T. Holladay, MD, MSEE, FACS, discusses how to help the cataract surgery patient choose the best IOL.
Overcoming the PRK mindset: Incorporating LASIK, SMILE into the military
The reason for undergoing refractive surgery as a member of the U.S. military is not necessarily a medical one.
FDA approves VisuMax software update for ReLEx SMILE
FDA approves lifitegrast for dry eye disease
FDA approves Avedro’s cross-linking system for progressive keratoconus
DRCR.net Protocol T: At 2 years, Eylea, Avastin, Lucentis all reduce need for injections, improve visual acuity
FDA approves Kamra inlay implant for presbyopia
Excessive blinking may indicate ocular surface disease in children
Allergic eye disease and evaporative dry eye disease are the two main causes of pediatric ocular surface problems.
Femtosecond laser-assisted cataract surgery represents new frontier
Femtosecond laser-assisted cataract surgery, or FLACS, represents a new frontier in cataract surgery. This technology is relatively new, and therefore “teething problems” are inevitable. Since its introduction in 2008, a lot of enhancements have been achieved.
FDA approves Iluvien for treatment of DME
The U.S. Food and Drug Administration has approved Iluvien for the treatment of diabetic macular edema in patients previously treated with corticosteroids who did not have a significant increase in IOP, Alimera Sciences announced in a press release.
FDA approves Omidria for intraocular lens replacement surgery
Overwhelming changes to ICD codes pending, implementation deadline delayed
Implementation of ICD-10 will be a significant and daunting change for ophthalmology, according to several experts in the field.